• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Meta分析图的展示。

Presentation of meta-analysis plots.

作者信息

Wald N J, Bestwick J P

机构信息

Wolfson Institute of Preventive Medicine, Barts and the London, School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ

Wolfson Institute of Preventive Medicine, Barts and the London, School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ.

出版信息

J Med Screen. 2015 Mar;22(1):49-51. doi: 10.1177/0969141314556490.

DOI:10.1177/0969141314556490
PMID:25753762
Abstract

Meta-analysis (forest) plots are widely used to show the results from multiple individual randomized trials or observational studies that address the same question, including the assessment of screening markers. They show the between study spread of results and provide a summary estimate of the results from all the studies combined. We here illustrate the advantage of ordering study results by the magnitude of the effect and including a vertical shaded band encompassing the summary 95% confidence interval of the summary estimate to emphasize the uncertainty of the estimate in a way that is more prominent than only displaying a "diamond" around its value.

摘要

Meta分析(森林)图被广泛用于展示针对同一问题的多个个体随机试验或观察性研究的结果,包括筛查标志物的评估。它们展示了研究结果之间的差异,并提供了所有研究综合结果的汇总估计。我们在此说明了按效应大小对研究结果进行排序并纳入一个垂直阴影带的优势,该阴影带包含汇总估计的95%置信区间,以一种比仅在其值周围显示一个“菱形”更突出的方式强调估计的不确定性。

相似文献

1
Presentation of meta-analysis plots.Meta分析图的展示。
J Med Screen. 2015 Mar;22(1):49-51. doi: 10.1177/0969141314556490.
2
Antenatal screening for Down's syndrome.唐氏综合征的产前筛查
J Med Screen. 1997;4(4):181-246. doi: 10.1177/096914139700400402.
3
Prenatal screening for Down's syndrome using inhibin-A as a serum marker.使用抑制素A作为血清标志物进行唐氏综合征的产前筛查。
Prenat Diagn. 1996 Feb;16(2):143-53. doi: 10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F.
4
Evolution of an inhibin A ELISA method: implications for Down's syndrome screening.抑制素A酶联免疫吸附测定法的演变:对唐氏综合征筛查的影响
Ann Clin Biochem. 1998 Sep;35 ( Pt 5):656-64. doi: 10.1177/000456329803500510.
5
Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.二聚体抑制素A作为孕早期唐氏综合征的标志物。
N Engl J Med. 1996 May 9;334(19):1231-6. doi: 10.1056/NEJM199605093341904.
6
[Inhibin in pregnancy--a new screening marker for prenatal diagnosis?].[孕期抑制素——产前诊断的一种新筛查标志物?]
Ceska Gynekol. 2002 Mar;67(2):93-6.
7
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.孕中期使用孕妇血清二聚体抑制素A筛查唐氏综合征
J Med Screen. 1998;5(3):115-9. doi: 10.1136/jms.5.3.115.
8
Validation plots in antenatal screening for Down's syndrome.唐氏综合征产前筛查中的验证图。
J Med Screen. 2006;13(4):166-71. doi: 10.1177/096914130601300402.
9
SURUSS in perspective.透视下的SURUSS
Semin Perinatol. 2005 Aug;29(4):225-35. doi: 10.1053/j.semperi.2005.05.006.
10
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.一种适用于孕中期唐氏综合征筛查的新型二聚体抑制素A检测方法的临床验证
J Med Screen. 2001;8(1):2-7. doi: 10.1136/jms.8.1.2.

引用本文的文献

1
The addition of metformin to systemic anticancer therapy in advanced or metastatic cancers: a meta-analysis of randomized controlled trials.在晚期或转移性癌症的全身性抗癌治疗中添加二甲双胍:一项随机对照试验的荟萃分析。
Int J Med Sci. 2020 Sep 12;17(16):2551-2560. doi: 10.7150/ijms.50338. eCollection 2020.
2
Pathologic and prognostic impacts of amplification in gastric cancer: a meta-analysis and systemic review.扩增在胃癌中的病理及预后影响:一项荟萃分析与系统评价
J Cancer. 2019 Jun 2;10(11):2560-2567. doi: 10.7150/jca.29184. eCollection 2019.
3
Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials.
特发性血小板减少性紫癜的根除治疗:随机试验的荟萃分析
Gastroenterol Res Pract. 2018 Oct 9;2018:6090878. doi: 10.1155/2018/6090878. eCollection 2018.
4
The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials.他汀类药物添加至全身抗癌治疗的效果:一项随机对照试验的荟萃分析
J Clin Med. 2018 Oct 4;7(10):325. doi: 10.3390/jcm7100325.
5
Clinicopathologic Significance of Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review.透明细胞肾细胞癌中基因改变的临床病理意义:一项更新的荟萃分析和综述。
Int J Mol Sci. 2018 Aug 26;19(9):2529. doi: 10.3390/ijms19092529.
6
Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis.MET拷贝数增加在非小细胞肺癌中的预后价值:一项更新的荟萃分析。
J Cancer. 2018 Apr 23;9(10):1836-1845. doi: 10.7150/jca.24980. eCollection 2018.
7
The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials.抗表皮生长因子受体(EGFR)药物在局部晚期头颈癌患者中的作用:一项随机试验的荟萃分析
Oncotarget. 2017 Oct 20;8(60):102371-102380. doi: 10.18632/oncotarget.21987. eCollection 2017 Nov 24.
8
Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and review.分子靶向药物作为肝细胞癌二线治疗的Meta分析与综述
Oncotarget. 2017 Oct 3;8(60):102321-102327. doi: 10.18632/oncotarget.21454. eCollection 2017 Nov 24.
9
MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review.晚期非小细胞肺癌中的MET抑制剂:一项荟萃分析与综述
Oncotarget. 2017 Sep 11;8(43):75500-75508. doi: 10.18632/oncotarget.20824. eCollection 2017 Sep 26.
10
Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis.c-Met过表达在胰腺腺癌中的预后价值:一项荟萃分析。
Oncotarget. 2017 Aug 22;8(42):73098-73104. doi: 10.18632/oncotarget.20392. eCollection 2017 Sep 22.